Alamar Biosciences, Inc. — Investor Relations & Filings
Alamar Biosciences, Inc. is a commercial-stage proteomics company focused on powering precision proteomics for the earliest detection of disease. It develops and commercializes an automated, high-throughput, ultra-high sensitivity platform, including ARGO™ and NULISA™ technologies. This platform redefines protein biomarker detection by enabling the discovery of novel plasma biomarkers, even from low-volume specimens, that are often invisible with conventional immunoassays. The technology supports groundbreaking insights in biomarker discovery, drug development, and disease research, expanding applications across various conditions like Alzheimer's, TBI, and stroke, from pediatric to geriatric care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-08 | English | |
| 8-K | 2026-05-08 | English | |
| Major Shareholding Notification 2026 | 2026-04-23 | English | |
| Major Shareholding Notification 2026 | 2026-04-23 | English | |
| Regulatory Filings 2026 | 2026-04-21 | English | |
| S-8 | 2026-04-20 | English |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46725313 | 10-Q | 2026-05-08 | English | ||
| 46725306 | 8-K | 2026-05-08 | English | ||
| 46725314 | Major Shareholding Notification 2026 | 2026-04-23 | English | ||
| 46725315 | Major Shareholding Notification 2026 | 2026-04-23 | English | ||
| 46725316 | Regulatory Filings 2026 | 2026-04-21 | English | ||
| 46725319 | S-8 | 2026-04-20 | English | ||
| 46725321 | 8-K | 2026-04-20 | English | ||
| 46725323 | POS AM | 2026-04-20 | English | ||
| 46725325 | 424B4 | 2026-04-17 | English | ||
| 46725326 | Regulatory Filings 2026 | 2026-04-17 | English | ||
| 46725329 | S-1MEF | 2026-04-17 | English | ||
| 46725328 | Regulatory Filings 2026 | 2026-04-16 | English | ||
| 46725327 | S-1/A | 2026-04-16 | English | ||
| 46725330 | 8-A12B | 2026-04-15 | English | ||
| 46725336 | S-1/A | 2026-04-13 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Medicenna Therapeutics Corp.
A clinical-stage immunotherapy company developing novel eng…
|
MDNA | CA | Professional, scientific and te… |
|
Medicofarma Biotech Spolka Akcyjna
R&D company developing innovative medicines, medical device…
|
MDB | PL | Professional, scientific and te… |
|
Medigene AG
Develops TCR-guided immunotherapies for cancer; currently i…
|
MDG1 | DE | Professional, scientific and te… |
|
Medizen Humancare Inc Co., Ltd
A research company specializing in genomic analysis for per…
|
236340 | KR | Professional, scientific and te… |
|
Medpace Holdings, Inc.
A global CRO providing Phase I-IV clinical development for …
|
MEDP | US | Professional, scientific and te… |
|
MegaPro Biomedical Co. Ltd.
A clinical-stage biotech developing nanomedicines for oncol…
|
— | MY | Professional, scientific and te… |
|
MEMPHASYS LIMITED.
Develops cell separation solutions for human and animal rep…
|
MEM | AU | Professional, scientific and te… |
|
Metagenomi, Inc.
A genetic medicines company developing therapeutics with a …
|
MGX | US | Professional, scientific and te… |
|
MICROBA LIFE SCIENCES LIMITED
Analyzes gut microbiomes using metagenomic sequencing for t…
|
MAP | AU | Professional, scientific and te… |
|
Micromem Technologies Inc.
Specializes in designing and providing customized, highly s…
|
MRM | CA | Professional, scientific and te… |
Alamar Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72612/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72612 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72612 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72612 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72612}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alamar Biosciences, Inc. (id: 72612)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.